Boehringer Ingelheim (Canada) Ltd.
Registration:
1
of
3
(2022-05-16
to
2022-11-16)
Policies or Program
- Arranging meetings for the client to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
- Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB).